Ercros, S.A. (BME:ECR)

Spain flag Spain · Delayed Price · Currency is EUR
3.230
+0.110 (3.53%)
At close: Feb 27, 2026
11.19%
Market Cap 295.34M
Revenue (ttm) 662.79M
Net Income (ttm) -53.59M
Shares Out 91.44M
EPS (ttm) n/a
PE Ratio n/a
Forward PE 17.94
Dividend n/a
Ex-Dividend Date n/a
Volume 421,600
Average Volume 312,573
Open 3.130
Previous Close 3.120
Day's Range 3.120 - 3.300
52-Week Range 2.230 - 3.475
Beta 0.39
RSI 32.27
Earnings Date Feb 27, 2026

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. The Intermediate Chemical... [Read more]

Industry Chemicals
Sector Materials
Founded 1817
Employees 1,357
Stock Exchange Madrid Stock Exchange
Ticker Symbol ECR
Full Company Profile

Financial Performance

In 2025, Ercros's revenue was 662.79 million, a decrease of -0.81% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.

Financial Statements

News

There is no news available yet.